Experts Matter. Find Yours.

Connect for media, speaking, professional opportunities & more.

Disney and other corporations are being pushed into social and political battles

At one time, corporations didn't get get in the middle of social and political battles, according to David Primo, professor of political science and business administration at the University of Rochester. The Disney Corporation recently came out in opposition to Florida's "Don't Say Gay" law, and Primo says it was "dramatic" how quickly the state responded by removing the company's self-governing special district status. As Primo sees it, increased political polarization across the country is leading employees, consumers, and activists to push corporations to take positions on issues like police brutality and LGBTQ rights. The irony, though, is that Americans are polarized over whether corporations ought to be doing this. "In general, Democrats are highly supportive of this, and Republicans are not," says Primo. "It's pretty straight forward to think that a corporation ought to be taking positions on issues related to its core business operations," says Primo. "The challenge for an executive, who has a fiduciary responsibility to the company, is knowing where to draw the line." So, if a company stakes out a position, Primo says it's just as likely to alienate a significant portion of its consumer base, as it is to gain the support of another portion of its base.

David Primo
1 min. read

Forbes Ranks ChristianaCare as one of the Best Employers for Diversity and Inclusion in the United States for Second Consecutive Year

ChristianaCare also ranks as No. 2 overall health care employer nationwide for diversity and inclusion, No. 40 overall For the second consecutive year, Forbes magazine has ranked ChristianaCare as one of the best employers for diversity and inclusion in the United States in its list of Best Employers for Diversity 2022. ChristianaCare ranked as the No. 2 employer for diversity and inclusion in the health care industry and the No. 40 employer in the nation overall. “Through purposeful actions, we commit to valuing diversity and fostering an environment for inclusion as we support all caregivers and serve all our neighbors with love and excellence, in our actions and in our words,” said Neil Jasani, M.D., MBA, FACEP, chief people officer at ChristianaCare. “We know when we support our caregivers and they can be their authentic selves, they will be exceptional today and even better tomorrow.” ChristianaCare, Delaware’s largest private employer, has committed to being an anti-racism organization and works to ensure that commitment is reflected through the organization’s policies, programs, and practices. (Read more about ChristianaCare’s anti-racism commitment here.) All employees of ChristianaCare are referred to as caregivers, whether they provide direct patient care or support that care indirectly. ChristianaCare’s inclusion efforts include 10 employee resource groups, which connect caregivers who have a common interest or bond with one another. Formed by employees across all demographics – such as disability, gender, race, military status, national origin, sexual orientation, etc. – these voluntary grassroots groups work to improve inclusion and diversity at ChristianaCare. More than 1,100 caregivers at ChristianaCare participate in employee resource groups. ChristianaCare also has developed LeadershipDNA, a leadership development program that is specifically targeted to underrepresented, diverse populations early in their leadership journey within the organization and is designed to foster professional and career development. ChristianaCare President and CEO Janice E. Nevin, M.D., MPH, has signed the CEO Act!on for Diversity & Inclusion Pledge, which outlines a specific set of actions the signatory CEOs will take to cultivate a trusting environment where all ideas are welcomed, and employees feel comfortable and empowered to have discussions about diversity and inclusion. More than 1,600 of ChristianaCare’s caregivers have also signed the pledge. “This recognition shows that we are making progress in our commitment to invest in our caregivers and to make all who join us feel included,” said Pamela Ridgeway, chief diversity officer and vice president of talent at ChristianaCare. “Taking care of people is what we do, and our ability to help people achieve optimal health is tied directly to how successful we are at embracing diversity and creating an inclusive environment for our caregivers.” Forbes’ Best Employers for Diversity were identified from an independent survey of more than 60,000 U.S. employees working for companies employing at least 1,000 people in their U.S. operations. Respondents were asked to rate their organizations on criteria such as age, disability, ethnicity, gender and sexual orientation equality, as well as general diversity. More than 10,000 companies were reviewed and approximately 2,000 were given a diversity score that is derived from employee surveys and publicly available information. The final list ranks the 500 employers that not only received the most recommendations, but also have the most diverse boards and executive leadership, and the most proactive diversity and inclusion initiatives.

Neil Jasani, M.D., MBA, FACEP
3 min. read

Under new ownership - what's next for Twitter and the social media landscape

He said he'd do it - and he did. Billionaire, innovator and always the controversial CEO, Elon Musk scratched together over 40 billion dollars and has taken the reigns of social media giant Twitter. But now that thew deed is done - a lot of people have some concerns about Musk's intentions for the platform and its hundreds of thousands of users. Will there be an edit button? Will there finally be an end to 'bots'? And what about moderation and free speech? These are all valid and important questions to ask, and that's why Michigan State University's Anjana Susarla penned a recent piece in The Conversation to tackle those topics. What lies ahead for Twitter will have people talking and reporters covering for the days and weeks to come.  And if you're a journalist looking for insight and expert opinion - then let us help with your stories. Anjana Susarla is the Omura Saxena Professor of Responsible AI at Michigan State University. She's available to speak with media, simply click on her icon now to arrange an interview today.

Anjana Susarla
1 min. read

ChristianaCare Scientists Show for the First Time That Tumor Cells Can Manipulate the Body’s Natural Antibody Response to Triple Negative Breast Cancer

Findings point to potential new therapeutic targets for this highly aggressive, drug-resistant breast cancer subtype In breakthrough research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute, scientists have discovered that a protein secreted by tumor cells can switch off the body’s natural defenses against triple negative breast cancer (TNBC). The study, led by Jennifer Sims-Mourtada, Ph.D., lead research scientist at the Cawley Center for Translational Cancer Research (CTCR), at the Graham Cancer Center, is reported in The Journal of Translational Medicine, available online. “What we found is that TNBC tumor cells can effectively shut down the body’s defense systems against the tumor by secreting a type of protein called IL-10,” Dr. Sims-Mourtada said. “The presence of this immune system protein forces the antibodies that would normally be created to attack the tumor to become non-reactive and not do what they are supposed to do.” The study was initiated in partnership with The Wistar Institute of Philadelphia, Pennsylvania, in collaboration with the late Raj “Shyam” Somasundaram, Ph.D., a cell biologist at the Melanoma Research Center. “Dr. Sims-Mourtada and her team have brought us tantalizingly close to understanding what drives the aggressive nature of triple negative breast cancer, a treatment-starved disease that disproportionately affects Delaware women,” said Nicholas J. Petrelli, M.D., Bank of America endowed medical director of the Helen F. Graham Cancer Center & Research Institute. “Their work underscores our belief that scientific collaborations such as this one between our Cawley CTCR clinicians and Wistar scientists can smooth the way for new findings to become effective therapies, especially for hard-to-treat and aggressive forms of cancer like TNBC.” Understanding the mechanism behind TNBC Delaware ranks highest in the nation for incidence of triple negative breast cancer. TNBC is an aggressive form that affects Black women at twice the rate of white women with poorer outcomes. Patients have higher rates of early recurrence than other breast cancer subtypes, particularly in the first five years after diagnosis. Currently there is no targeted therapy for TNBC. “One of our missions within the Cawley CTCR is to understand the mechanisms behind TNBC and find a treatment for it,” Dr. Sims-Mourtada said. “Our study sheds new light on what is prompting the body’s immune response to the cancer cells and offers clues to potential new therapeutic targets.” Normally it is the job of the B cells to regulate the immune response against foreign invaders like cancer. Among other jobs, they control inflammation at the site of an attack by releasing proteins including IL-10 to signal the defender cells to stand down. “Previously it was thought that the immune cells were the ones to express IL-10 to regulate themselves,” Dr. Sims-Mourtada said. “But our study shows that the tumor cells also release this protein, which means they are driving how the immune system behaves.” Within the tumor microenvironment, IgG4 is one of four antibody subclasses expressed and secreted by B cells. Whereas another type of antibody would urge the immune system to press on with the attack, activation of IgG4 signals the job is done. TNBC and activation of IgG4 “Our findings support that TNBC may create a tumor environment that supports activation of IgG4, and messaging from IL10 is triggering the switch,” Dr. Sims-Mourtada said. As previously reported with other cancers, such as melanoma, this study confirms that the presence of IgG4-positive B cells within the tumor associates with advanced disease increased recurrence and poor overall breast cancer survival. It is also possible that IL-10 expression by tumor cells may also be a cause of poor outcomes in TNBC, and this may be independent of IgG4+ B cells. “At this point, we don’t know what causes tumor cells to start secreting IL-10, but we know that B cell-tumor cell interactions are involved,” Dr. Sims-Mourtada said. “We still have to look at what is really going on in the B cell population to determine which subtypes of B cells are affected by this tumor crosstalk and why some forms of TNBC express IL-10 (the ones with poor outcomes) and others do not. “We think that the presence or absence of other immune cells in the microenvironment may affect how B cells interact with tumor cells to drive IL-10 expression,” she said. Resources for the study, including blood and tissue samples from consenting patients, were obtained through the Graham Cancer Center’s Tissue Procurement program. Interestingly, in a small subset of samples, the researchers found that IL-10 expression was significantly higher in Black patients than non-Hispanic white patients. These findings need to be confirmed in a larger more diverse population with different TNBC subtypes. Understanding tumor-infiltrating B cells “Our growing understanding of the contribution of IgG4+ cells to the immune microenvironment of TNBC and what drives IL-10 expression may reveal ways in which tumor-infiltrating B cells can contribute to tumor growth and provide new targets to increase the immune response to TNBC,” Dr. Sims-Mourtada said. As partners for more than a decade, Graham Cancer Center research clinicians and Wistar scientists collaborate across disciplines to translate cancer research into more effective therapies for patients everywhere. In addition to providing high-quality, viable tissue samples for Wistar research studies, Graham Cancer Center clinicians actively participate in concept development, sharing their unique understanding of the everyday patient experience.

4 min. read

Balfour Beatty group CEO and Aston University visiting professor predicts decade of UK infrastructure growth

Leo Quinn says transport, defence and energy projects are set to benefit from potential government-funded boom The UK Government has committed £4.8bn for infrastructure investment in towns across the country Balfour Beatty is working on a number of projects including Hinkley Point C and HS2. A decade of UK ‘infrastructure growth’ has been predicted by Balfour Beatty CEO and Aston University visiting professor, Leo Quinn, as the construction industry gets ready for a potential boom following financial commitments from the Government. £4.8bn has been promised for infrastructure investment in towns across the country and £26bn for public capital investment to hit emissions targets as part of the Government’s ‘levelling up’ agenda to raise living standards in regions outside of London. Leo Quinn said: “If you start to look at infrastructure and you look at either HS2, you look at nuclear - in terms of defence nuclear or civil nuclear - you look at the green agenda . . . we are entering into an era of 10 years of infrastructure growth. “I think the future looks very optimistic.” Balfour Beatty, the UK’s largest construction group, is working on a number of projects, including Hinkley Point C, the first new nuclear power station built in the UK in more than 20 years, and HS2, the high-speed rail link between London and the north of England. Overall, the UK group and French construction company Vinci have secured about £6bn in HS2 projects as part of a joint venture. This includes a £5bn civil engineering contract for the stretch of HS2 between Warwickshire and Staffordshire and a £1bn construction management deal for Old Oak Common station in north London, alongside engineering group Systra. The group was also awarded a £52m contract to deliver ‘environmental works’ across the HS2 route from the West Midlands to Crewe, creating new habitats along this 64km section of track.

2 min. read

Aston Institute of Health and Neurodevelopment officially launches new £2.8m MRI scanner

A new £2.8 million MRI scanner has been unveiled at Aston University. The showcase took place in Aston Institute of Health and Neurodevelopment on Monday 25 April. The event was attended by Aston University Interim Vice-Chancellor Saskia Loer Hansen and other members of the University executive team, together with academic researchers in the University’s College of Health and Life Sciences. After an official ribbon-cutting ceremony hosted by the Institute co-directors Professor Jackie Blissett and Professor Gavin Woodhall, guests were invited to take a tour of the new MRI scanner facilities where imaging researchers were on hand to showcase and discuss their research for which the new MRI scanner is a vital facility. Interim Vice-Chancellor Saskia Loer Hansen said: “I am delighted that Aston Institute of Health and Neurodevelopment is home to this state-of-the-art facility. Having a new MRI scanner on our campus will not only enable our scientists to undertake their neuroimaging research, but will also benefit so many patients in the region who urgently need this facility as part of their medical treatment. “Our new MRI scanner further highlights the world-class research that our scientists are undertaking at Aston University.” The new Siemens MAGNETOM Prisma 3T MRI scanner was installed over a period of four months starting in November 2021, including the work undertaken to remove the old machine from the building. The scanner has been made ‘child friendly’ with suitable images and the room which hosts the scanner has a wall mural of cherry blossom trees. The new MRI scanner will enhance the world-class neuroimaging research facilities within the Institute of Health and Neurodevelopment and support the development of the next generation of researchers. Professor Jackie Blissett, co-director of Aston Institute of Health and Neurodevelopment, said: “The new MRI scanner will enhance the world-class neuroimaging research facilities within the Institute of Health and Neurodevelopment. It will allow us to answer the questions that matter to children and young people, their families and the services that support them.” Aston University researchers use advanced neuroimaging techniques to examine brain health in children with neurological diseases and developmental disorders and are developing a research programme focused on children and young people to deliver a new understanding of development, disorder and disease and the interventions that will make a difference. The new scanner will also enable the Institute to provide the most recent innovations in MRI for patients visiting through the clinical service Aston University Imaging. Patients visiting for MRI scans come through private referrals, as well as from local institutions such as the Birmingham Royal Ballet and Aston Villa Football Club.

Jackie Blissett
2 min. read

Disney, DeSantis, and Corporate Dilemmas

The Florida state legislature recently voted to end the Walt Disney Co.’s special tax district, which has permitted the Orlando amusement park to govern its land and save millions each year in taxes. The decision followed a clash between Disney executives and Florida Gov. Ron DeSantis over recent legislation that prohibits instruction on sexual orientation or gender identity for children in kindergarten through Grade 3. UConn's Professor Robert Bird, the Eversource Energy Chair in Business Ethics and past president of the Academy of Legal Studies in Business, sat down with UConn Today to talk about clash between the corporation and Florida government as well as the implications for other companies that may be facing similar moral and ethical dilemmas: Q: There are so many layers to this story, from taxation to self-governance, political power to human rights. What strikes you as most significant? From one perspective, this is a debate over the role of LGBTQ+ education in schools. From another perspective, this raises the broader issue of the implications of private companies speaking and acting on matters of public policy. Corporations can no longer remain neutral or silent on major issues facing American society. Consumers, employees, shareholders, and the public are increasingly expecting companies to take a stand on controversies that matter to them. Just as some companies are being punished for not severing their relationships with Russia, because of Russia’s invasion of Ukraine, so are companies like Disney expected to speak out against public policies that contradict the values of its stakeholders. Q: Why does Disney play an important role in this issue? Disney is an important participant in the underlying “Don’t Say Gay” dispute. Disney has a powerful public brand and takes care to cultivate a family-friendly image worldwide. Disney has also been a long-standing leader in supporting LGBTQ+ rights. Disney has provided health benefits to same-sex partners since 1995, and allowed “Gay Days” at Walt Disney World since 1991. Public opinion was more hostile toward LGBTQ+ rights then, and Disney stood by its values even with the ensuing controversy. For Disney to “stand down” when so many people were advocating for Disney’s support in opposition to the bill, would have eroded its long-standing support of gay rights generally. Q: What message does this send to other CEOs who might be caught in a moral, ethical, or environmental debate with government leaders? The message sent to other companies is that politicians will not remain idle if a company opposes favored legislation or enters the sphere of public debate. Firms need to walk a fine line between standing up for their values and eroding relationships with political leaders. This is an important story, and if you're a reporter looking to know more or would like to schedule and interview with Professor Bird, then let us help. Click on his icon now to arrange an interview today.

Robert Bird
2 min. read

Will tourism bounce back as the Sunshine State gets ready for a post-COVID return?

The COVID-19 pandemic wreaked havoc on the globe, leaving few industries untouched in its wake. Florida’s tourism industry was hit particularly hard, with resorts shuttered and millions of visitors to the Sunshine State canceling their vacation plans. In fact, it’s estimated Walt Disney World lost more than $7 billion in 2020, all because of COVID. But with Florida back open and visitors returning, what's next for hospitality and tourism? And how will organizations handle staffing, pricing, inflation and other issues? If you are a journalist looking to cover the tourism sector in Florida, let us help. Peter Ricci is a clinical associate professor and director of the Hospitality and Tourism Management program in FAU’s College of Business. He is a hospitality industry veteran with more than 20 years of managerial experience in segments including food service, lodging, incentive travel and destination marketing. Peter is available to speak with the media. Simply click on his icon to arrange an interview.

Peter Ricci, Ed.D.
1 min. read

Aston University launches community project to promote healthy lives in East Birmingham

The Knowledge Exchange project is led by Aston University with Birmingham Community Healthcare NHS Foundation Trust, in partnership with Citizens UK It aims to identify local barriers that lead to poor health outcomes A total of £6,390 has been awarded to five projects to support local residents. Aston University and Birmingham Community Healthcare NHS Foundation Trust, in partnership with Citizens UK, have launched a community project to identify local barriers that lead to poor health outcomes. Dr Céline Benoit (Sociology and Policy), Dr Alexis Paton (Sociology and Policy), Dr Angela Jeffery (RKE) and Aisha Masood (RKE) have been leading on the Knowledge Exchange project in East Birmingham to help improve health and wellbeing. On 17 March, the team hosted the first community sandpit at Aston University, where a number of community-led organisations and charities came together to identify small-scale projects to support local residents and promote healthy lives. A total of £6,390 was awarded to five projects which will submit a report by 31 July 2022 and meet again in the autumn to share their journeys with each other as well as representatives from the NHS and Birmingham City Council. Dr Céline Benoit, associate dean for public engagement for the College of Business and Social Sciences at Aston University, said: “It was such a privilege to host a community sandpit at Aston University and have the NHS and local organisations talk to one another and come up with joint projects to help promote health and wellbeing in East Birmingham. “It was truly inspiring to see how many brilliant projects were put forward. “It not only helped us get a better understanding of the challenges local residents face when it comes to health and accessing healthcare services, but it was also a great reminder of how much we can achieve when we work collaboratively”.

2 min. read

What the CDC's Updated Developmental Guidelines Mean for Parents

The Centers for Disease Control and Prevention (CDC) recently revamped their developmental guidelines for children for the first time in years, allowing parents to know earlier if their kids may be experiencing any delays.  Villanova University nursing professor Michelle Kelly, PhD, CRNP, CNE, recently commented on the new guidelines: "The CDC and American Academy of Pediatrics (AAP), in response to birth provider and parent input, took a critical look at existing developmental milestones tools and handouts. Surveillance and handouts are typically parent facing items that can be used to determine if a child is meeting age-expected developmental targets." "That is in contrast to screening which is more structured, based on the surveillance but done by a primary care provider and used for referral for services, and evaluation which is done by a developmental specialist with the intent to diagnosis." "The CDC and AAP have done a thorough overhaul of developmental milestone surveillance (as opposed to screening and evaluation) to attempt to make the milestones 'evidence-based' and where possible norm-referenced." "Another major change is that the milestones are set for greater than 75%, rather than 50%. This means they are targets that 75% of children that age would have met. This eliminates phrases in the previous milestones that were confusing, such as a child 'may begin' a task at one age, but also should be doing it at the next age." "Perhaps the biggest win for children born preterm and others at risk for developmental delays is the 75% expectation virtually eliminates the 'wait and see' that occurred when the expectation was that 50% of children would exhibit a skill at that age. This means that families who have concerns, or whose children are not meeting the age-appropriate milestones, should be more readily referred for evaluation and intervention." "Additionally, an increased emphasis is placed, compared to the previous version, on open-ended questions to elicit parent concerns and ways for families to promote age-appropriate development."

Michelle Kelly, PhD
2 min. read